These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24135284)

  • 1. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.
    Ell B; Mercatali L; Ibrahim T; Campbell N; Schwarzenbach H; Pantel K; Amadori D; Kang Y
    Cancer Cell; 2013 Oct; 24(4):542-56. PubMed ID: 24135284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis.
    Kitayama K; Kawamoto T; Kawakami Y; Hara H; Takemori T; Fujiwara S; Yahiro S; Miyamoto T; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror.
    Waning DL; Mohammad KS; Guise TA
    Cancer Cell; 2013 Oct; 24(4):407-9. PubMed ID: 24135278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
    Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
    Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
    Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
    Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
    David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
    PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein.
    Kuo PL; Liao SH; Hung JY; Huang MS; Hsu YL
    Biochim Biophys Acta; 2013 Jun; 1830(6):3756-66. PubMed ID: 23458685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.
    Li X; Liang Y; Lian C; Peng F; Xiao Y; He Y; Ma C; Wang Y; Zhang P; Deng Y; Su Y; Luo C; Kong X; Yang Q; Liu T; Hu G
    Theranostics; 2021; 11(20):9821-9832. PubMed ID: 34815788
    [No Abstract]   [Full Text] [Related]  

  • 9. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche.
    Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F
    J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis.
    Clohisy DR; Palkert D; Ramnaraine ML; Pekurovsky I; Oursler MJ
    J Orthop Res; 1996 May; 14(3):396-402. PubMed ID: 8676252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p.
    Yu L; Sui B; Fan W; Lei L; Zhou L; Yang L; Diao Y; Zhang Y; Li Z; Liu J; Hao X
    J Extracell Vesicles; 2021 Jan; 10(3):e12056. PubMed ID: 33489015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
    Marino S; Bishop RT; Mollat P; Idris AI
    Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signaling.
    Sung B; Oyajobi B; Aggarwal BB
    Mol Cancer Ther; 2012 Feb; 11(2):350-9. PubMed ID: 22090419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.
    Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y
    Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
    Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
    Ohno H; Kubo K; Murooka H; Kobayashi Y; Nishitoba T; Shibuya M; Yoneda T; Isoe T
    Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.
    Ang ES; Pavlos NJ; Chim SM; Feng HT; Scaife RM; Steer JH; Zheng MH; Xu J
    J Cell Biochem; 2012 Mar; 113(3):946-55. PubMed ID: 22034016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo.
    Marino S; Bishop RT; Carrasco G; Logan JG; Li B; Idris AI
    Calcif Tissue Int; 2019 Aug; 105(2):193-204. PubMed ID: 30929064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts.
    Grano M; Mori G; Minielli V; Cantatore FP; Colucci S; Zallone AZ
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1097-100. PubMed ID: 10772956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
    Frantzias J; Logan JG; Mollat P; Sparatore A; Del Soldato P; Ralston SH; Idris AI
    Br J Pharmacol; 2012 Mar; 165(6):1914-1925. PubMed ID: 21955294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.